2 unknown, 1 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 2, Completed 1 |
Follow Hao Long: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Perioperative Music Therapy Plus Oxycodone in Perioperative Management of Lung Surgery Perioperative Music Therapy - Analgesia, Lung Cancer | Phase 2 | Completed | Hao Long | 66 | 2023-08-01 | 2024-07-17 |
| Predictive Biomarker for Efficacy and Safety of Combination of Chemotherapy and Tislelizumab in NSCLC Tislelizumab 200 mg, Carboplatin AUC 5, pemetrexed 500mg/m2 - Tislelizumab, Safety | Phase 2 | Unknown | Hao Long | 100 | 2020-12-22 | 2022-02-17 |
| Neoadjuvant Toripalimab Plus Platinum-based Doublet for Stage III Non-small Cell Lung Cancer Albumin-bound paclitaxel, Carboplatin, Toripalimab - Non Small Cell Lung Cancer | Phase 2 | Unknown | Hao Long | 30 | 2019-08-01 | 2021-05-06 |
Agnosia (1) · Anxiety Disorders (1) · Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1)
Carboplatin (2) · 130-nm albumin-bound paclitaxel (1) · Albumin-Bound Paclitaxel (1) · Paclitaxel (1) · Pemetrexed (1) · tislelizumab (1) · toripalimab (1)
China (3)
PMID 34712513, PMID 35857536, PMID 39108262, PMID 39617319, PMID 41499358